BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3608164)

  • 1. Improved liquid-chromatographic assay of labetalol in plasma.
    Luke DR; Matzke GR; Clarkson JT; Awni WM
    Clin Chem; 1987 Aug; 33(8):1450-2. PubMed ID: 3608164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic assay for labetalol in human plasma using a PRP-1 column and fluorometric detection.
    Alton KB; Leitz F; Bariletto S; Jaworsky L; Desrivieres D; Patrick J
    J Chromatogr; 1984 Nov; 311(2):319-28. PubMed ID: 6520179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High pressure liquid chromatography on labetalol in serum or plasma.
    Woodman TF; Johnson B
    Ther Drug Monit; 1981; 3(4):371-5. PubMed ID: 7336471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of an automated sample processor and a polymer-based high-performance liquid chromatographic column to determine the pharmacokinetics of labetalol in man.
    Bates J; Carey PF; Godward RE
    J Chromatogr; 1987 Jun; 395():455-61. PubMed ID: 3624360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of fluorescence detection for the determination of labetalol in plasma by high-performance liquid chromatography.
    Ostrovská V; Svobodová X; Pechová A; Kusala S; Svoboda M
    J Chromatogr; 1988 Jul; 446():323-7. PubMed ID: 3209660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic assay for dilevalol in human plasma and urine using a PRP-1 column and fluorimetric detection.
    Alton KB; Petruzzi RF; Patrick JE
    J Chromatogr; 1988 Mar; 425(2):363-72. PubMed ID: 2897376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The determination of labetalol in plasma by high-performance liquid chromatography using fluorescence detection.
    Meredith PA; McSharry D; Elliott HL; Reid JL
    J Pharmacol Methods; 1981 Dec; 6(4):309-14. PubMed ID: 7334812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved high-performance liquid chromatographic determination of amphotericin B in human serum and plasma.
    Hosotsubo H; Hosotsubo K
    J Pharm Biomed Anal; 1989; 7(8):975-9. PubMed ID: 2490106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive high-performance liquid chromatographic method for the determination of labetalol diastereoisomers in plasma samples without derivatization.
    Grellet J; Michel-Gueroult P; Ducint D; Saux MC
    J Chromatogr; 1994 Jan; 652(1):59-66. PubMed ID: 8014228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination kinetics of labetalol in severe renal failure.
    Wood AJ; Ferry DG; Bailey RR
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):81S-86S. PubMed ID: 7093103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent measurement of flecainide acetate and propranolol by normal-phase high-performance liquid chromatography.
    Rognerud CL; Ou CN
    Clin Chem; 1989 May; 35(5):857-60. PubMed ID: 2498017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic assay for etoposide in human plasma.
    Hersh MR; Ludden TM
    J Pharm Sci; 1986 Aug; 75(8):815-7. PubMed ID: 3772756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic assay for the quantitation of nadolol in human plasma using fluorescence detection.
    Srinivas NR; Shyu WC; Shah VR; Campbell DA; Barbhaiya RH
    Biomed Chromatogr; 1995; 9(2):75-9. PubMed ID: 7795389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive high-performance liquid chromatographic method for direct separation of labetalol stereoisomers in biological fluids using an alpha 1-acid glycoprotein stationary phase.
    Doroudian A; Yeleswaram K; Rurak DW; Abbott FS; Axelson JE
    J Chromatogr; 1993 Sep; 619(1):79-86. PubMed ID: 8245166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High performance liquid chromatographic assay for the simultaneous determination of midazolam and ketoconazole in plasma.
    Hamdy DA; Brocks DR
    J Pharm Biomed Anal; 2010 Nov; 53(3):617-22. PubMed ID: 20537491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High performance liquid chromatographic determination of cyclooxygenase II inhibitor rofecoxib in rat and human plasma.
    Jamali F; Sattari S
    J Pharm Pharm Sci; 2000; 3(3):312-7. PubMed ID: 11177649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic assay of alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol (BMY 14802), a potential antipsychotic drug, in monkey and rat plasma.
    Janiszewski JS; Shukla UA; Kaul S; Dandekar KA; Pittman KA
    J Chromatogr; 1991 Jun; 567(1):274-81. PubMed ID: 1918256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous quantitation of etoricoxib, salicylic acid, valdecoxib, ketoprofen, nimesulide and celecoxib in plasma by high-performance liquid chromatography with UV detection.
    Pavan Kumar VV; Vinu MC; Ramani AV; Mullangi R; Srinivas NR
    Biomed Chromatogr; 2006 Jan; 20(1):125-32. PubMed ID: 16013036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid-chromatographic determination of five orally active cephalosporins--cefixime, cefaclor, cefadroxil, cephalexin, and cephradine--in human serum.
    McAteer JA; Hiltke MF; Silber BM; Faulkner RD
    Clin Chem; 1987 Oct; 33(10):1788-90. PubMed ID: 3665031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective determination of unchanged and glucuroconjugated eliprodil, a new anti-ischaemic drug, in human plasma and urine by precolumn derivatization and column-switching high-performance liquid chromatography with fluorescence detection.
    Malavasi B; Ripamonti M; Rouchouse A; Ascalone V
    J Chromatogr A; 1996 Apr; 729(1-2):323-33. PubMed ID: 9004957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.